Objective: Among patients with peripheral artery disease (PAD), depression is diagnosed in 17-25% and negatively impacts wound healing, quality of life, and survival. We hypothesized that depression is underdiagnosed in patients with PAD. Additionally, given the associations between depression and mortality in PAD patients, there is an increased need to investigate the strength of this relationship. The present analysis includes two studies to address the following aims: 1) Investigation of the prevalence of concomitant PAD and depression in a cohort from the Southeastern United States, and 2) Examination of the association between depression and all-cause mortality in a cohort of Canadian patients with PAD.
Methods: STUDY 1: From June -August 2022, the Patient Health Questionnaire Module 9 (PHQ-9) was administered to all patients seeking PAD-related care including medical, wound/podiatric, or vascular interventional/surgical treatment, in the UNC Vascular, Wound, and Podiatry clinics. The PHQ-9 assesses symptoms over two weeks and is scored 0-27, with higher scores indicating increasingly severe depression. Demographics, primary diagnosis, depression history, and antidepressant prescription were determined through chart review. We compared the proportion of positive depression screenings (PHQ-9 ≥ 5) to known depression. Among those treated for depression, the PHQ-9 score severity was evaluated. T-tests and χ2 tests were used to compare means and proportions. STUDY 2: From July 2015 - October 2016, the Geriatric Depression Scale Short Form (GDS-S) was administered to adult patients with PAD undergoing revascularization. The GDS-S is a self-report measure of depression with a score >5 consistent with depression. The prevalence of depression was determined; primary outcome was all-cause mortality at 6 months.
Results: STUDY 1: In 104 PAD patients (mean age 66.6 ± 11.3 years, 37% female), 37% of respondents scored ≥ 5 on the PHQ-9 survey, indicating at least mild depression. Only 18% of PAD patients had a history of depression, demonstrating a significant difference between the PHQ-9 findings and documented medical history. While depression was underdiagnosed in both men and women, men were more likely to have unrecognized depression (Chi-squared statistic = 35.117, df = 1, p < 0.001). Among those with a history of depression, 74% had a current prescription for antidepressant medication, but 57% still had an elevated PHQ-9 score indicating possible undertreatment. STUDY 2: In 148 patients (mean age 70.3 ± 11.0 years, 39% female) the prevalence of screened depression was 28.4%, but only 3.3% had a documented history of depression suggesting significant underdiagnosis. Patients with depression were significantly more likely to die within six months of revascularization (9.5% vs. 0.9%; OR 1.48, 95% CI: 1.08 to 2.29). There was no association between depression and risk of length of stay, reintervention, or readmission.
Conclusions: Depression is underdiagnosed and under-treated among patients with PAD, which has grave consequences as it is associated with 1.5 times the odds of mortality within six months of revascularization. There is a critical need for more robust screenings and comprehensive mental health treatment for patients with concomitant depression and PAD.
Click to expand...